Tissue factor pathway inhibitor and bleeding tendency: can hormonal state explain the differences?
Blood Adv
.
2021 Jun 8;5(11):2516-2517.
doi: 10.1182/bloodadvances.2021004651.
Authors
Anders Erik Astrup Dahm
1
2
,
Per Morten Sandset
2
3
4
Affiliations
1
Department of Hematology, Akershus University Hospital, Lørenskog, Norway.
2
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
3
Department of Haematology.
4
Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.
PMID:
34086862
PMCID:
PMC8238490
DOI:
10.1182/bloodadvances.2021004651
No abstract available
Publication types
Letter
Comment
MeSH terms
Blood Coagulation Disorders*
Hemorrhagic Disorders*
Humans
Lipoproteins
Substances
Lipoproteins
lipoprotein-associated coagulation inhibitor